Harshal Nandurkar Selected Research

Polycythemia (Erythrocytosis)

1/2019

Hemopoietic Cell Kinase amplification with Protein Tyrosine Phosphatase Receptor T depletion leads to polycythemia, aberrant marrow erythoid maturation, and splenomegaly.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harshal Nandurkar Research Topics

Disease

6	Venous Thromboembolism 04/2024 - 04/2018
6	Hemorrhage 08/2023 - 06/2014
5	Thrombosis (Thrombus) 04/2024 - 07/2011
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 07/2019
4	Thrombophilia 04/2024 - 09/2017
4	Infections 10/2022 - 05/2004
3	Stroke (Strokes) 01/2023 - 06/2014
3	Hematologic Neoplasms (Hematological Malignancy) 03/2015 - 09/2011
2	COVID-19 04/2024 - 10/2022
2	Chronic Renal Insufficiency 04/2024 - 01/2023
2	Heart Arrest (Cardiac Arrest) 01/2024 - 07/2023
2	Obesity 01/2023 - 12/2022
2	Venous Thrombosis (Deep-Vein Thrombosis) 12/2022 - 04/2014
2	Neoplasms (Cancer) 04/2019 - 01/2019
2	Thrombotic Microangiopathies 07/2017 - 07/2015
1	Diabetes Mellitus 04/2024
1	Overweight 03/2024
1	Ischemic Stroke 01/2023
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Hypertension (High Blood Pressure) 03/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2019
1	Chronic Hepatitis B 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Polycythemia (Erythrocytosis) 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Hepatitis B 01/2019
1	Splenomegaly 01/2019
1	von Willebrand Diseases (von Willebrand's Disease) 01/2017
1	Pulmonary Arterial Hypertension 12/2016
1	Systemic Scleroderma (Systemic Sclerosis) 12/2016
1	Gastric Antral Vascular Ectasia (Watermelon Stomach) 11/2015
1	Multiple Myeloma 07/2015
1	Hematoma 06/2014
1	Cerebral Hemorrhage 06/2014
1	Pure Red-Cell Aplasia 03/2014
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 03/2014
1	Anemia 05/2013
1	Eosinophilia 11/2012
1	Myositis (Idiopathic Inflammatory Myopathies) 11/2012
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2012
1	Vasculitis (Vasculitides) 11/2012
1	Hypothermia 07/2011
1	Thrombocytopenia (Thrombopenia) 07/2011

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 04/2024 - 06/2014
4	FibrinIBA 04/2024 - 04/2018
3	AnticoagulantsIBA 01/2019 - 12/2016
2	Hemostatics (Antihemorrhagics)IBA 12/2022 - 10/2022
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2022 - 08/2021
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2012
2	Thrombin FDA Link 07/2019 - 04/2018
2	Rituximab (Mabthera)FDA Link 05/2010 - 10/2009
1	fibrin fragment D (D-dimer)IBA 04/2024
1	Oxygen (Dioxygen)IBA 07/2023
1	Adenosine Triphosphate (ATP)IBA 07/2023
1	Pyruvic Acid (Pyruvate)IBA 07/2023
1	Ionotropic Glutamate ReceptorsIBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Hormones (Hormone)IBA 07/2022
1	Messenger RNA (mRNA)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	MethyltransferasesIBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Protein Tyrosine PhosphatasesIBA 01/2019
1	entecavir FDA Link 01/2019
1	Tenofovir (Viread)FDA Link 01/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019
1	Vitamin K FDA Link 04/2018
1	Warfarin (Coumadin)FDA LinkGeneric 09/2017
1	Oxycodone (Oxycontin)FDA LinkGeneric 07/2017
1	von Willebrand FactorIBA 01/2017
1	apixabanIBA 12/2016
1	Imatinib Mesylate (Gleevec)FDA Link 11/2015
1	Bortezomib (Velcade)FDA Link 07/2015
1	src-Family KinasesIBA 03/2015
1	Tranexamic Acid (AMCA)FDA Link 06/2014
1	vinyltriethoxysilane (VTES)IBA 04/2014
1	HematinicsIBA 05/2013
1	Anaplastic Lymphoma KinaseIBA 11/2012
1	Fibrinogen (Factor I)FDA Link 07/2011
1	P-2 (P 2)IBA 07/2011
1	Purinergic P2 Receptors (ADP Receptor)IBA 07/2011
1	P-SelectinIBA 07/2011
1	Adenosine Diphosphate (ADP)IBA 07/2011

Therapy/Procedure

7	Therapeutics 03/2022 - 06/2014
5	Drug Therapy (Chemotherapy) 04/2019 - 10/2009
3	Arthroplasty 03/2024 - 12/2022
1	Resuscitation 01/2024
1	Length of Stay 08/2023
1	Heterologous Transplantation (Xenotransplantation) 01/2021
1	Intravenous Injections 07/2017
1	Lab-On-A-Chip Devices 01/2017
1	Duration of Therapy 06/2016
1	Palliative Care (Palliative Therapy) 09/2011
1	Induced Hypothermia 07/2011